Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
50
Expiration
Jan 15, 2027
DTE
100d
Moneyness
OTM
Intrinsic
$0.00
EWTX 50 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $0.15 | -25.00% | 3,045 | 1,620 |
| Nov 20, 2026 | 44d | $1.61 | -56.25% | 40 | 29 |
| Dec 18, 2026 | 72d | $1.85 | -28.85% | 3,001 | 3,001 |
| Jan 15, 2027 | 100d | $2.31 | -21.69% | 5 | 7 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
| Mar 19, 2027 | 163d | — | — | 0 | 0 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.